The impact of hypoxia-inducible factors in the pathogenesis of kidney diseases: a link through cell metabolism

Kidneys are sensitive to disturbances in oxygen homeostasis. Hypoxia and activation of the hypoxia-inducible factor (HIF) pathway alter the expression of genes involved in the metabolism of renal and immune cells, interfering with their functioning. Whether the transcriptional activity of HIF protects the kidneys or participates in the pathogenesis of renal diseases is unclear. Several studies have indicated that HIF signaling promotes fibrosis in experimental models of kidney disease. Other reports showed a protective effect of HIF activation on kidney inflammation and injury. In addition to the direct effect of HIF on the kidneys, experimental evidence indicates that HIF-mediated metabolic shift activates inflammatory cells, supporting the HIF cascade as a link between lung or gut damage and worsening of renal disease. Although hypoxia and HIF activation are present in several scenarios of renal diseases, further investigations are needed to clarify whether interfering with the HIF pathway is beneficial in different pathological contexts

Biseugenol Exhibited Anti-Inflammatory and Anti-Asthmatic Effects in an Asthma Mouse Model of Mixed-Granulocytic Asthma

In the present work, the anti-inflammatory and antiasthmatic potential of biseugenol, isolated as the main component from n-hexane extract from leaves of Nectandra leucantha and chemically prepared using oxidative coupling from eugenol, was evaluated in an experimental model of mixed-granulocytic asthma. Initially, in silico studies of biseugenol showed good predictions for drug-likeness, with adherence to Lipinski’s rules of five (RO5), good Absorption, Distribution, Metabolism and Excretion (ADME) properties and no alerts for Pan-Assay Interference Compounds (PAINS), indicating adequate adherence to perform in vivo assays. Biseugenol (20 mg·kg−1) was thus administered intraperitoneally (four days of treatment) and resulted in a significant reduction in both eosinophils and neutrophils of bronchoalveolar lavage fluid in ovalbumin-sensitized mice with no statistical difference from dexamethasone (5 mg·kg−1). As for lung function parameters, biseugenol (20 mg·kg−1) significantly reduced airway and tissue damping in comparison to ovalbumin group, with similar efficacy to positive control dexamethasone. Airway hyperresponsiveness to intravenous methacholine was reduced with biseugenol but was inferior to dexamethasone in higher doses. In conclusion, biseugenol displayed antiasthmatic effects, as observed through the reduction of inflammation and airway hyperresponsiveness, with similar effects to dexamethasone, on mixed-granulocytic ovalbumin-sensitized miceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FAPESP: 2018/06088-

Protective Effects of Anti-IL17 on Acute Lung Injury Induced by LPS in Mice

Introduction: T helper 17 (Th17) has been implicated in a variety of inflammatory lung and immune system diseases. However, little is known about the expression and biological role of IL-17 in acute lung injury (ALI). We investigated the mechanisms involved in the effect of anti-IL17 in a model of lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice.Methods: Mice were pre-treated with anti-IL17, 1h before saline/LPS intratracheal administration alongside non-treated controls and levels of exhaled nitric oxide (eNO), cytokine expression, extracellular matrix remodeling and oxidative stress, as well as immune cell counts in bronchoalveolar lavage fluid (BALF), and respiratory mechanics were assessed in lung tissue.Results: LPS instillation led to an increase in multiple cytokines, proteases, nuclear factor-κB, and Forkhead box P3 (FOXP3), eNO and regulators of the actomyosin cytoskeleton, the number of CD4+ and iNOS-positive cells as well as the number of neutrophils and macrophages in BALF, resistance and elastance of the respiratory system, ARG-1 gene expression, collagen fibers, and actin and 8-iso-PGF2α volume fractions. Pre-treatment with anti-IL17 led to a significant reduction in the level of all assessed factors.Conclusions: Anti-IL17 can protect the lungs from the inflammatory effects of LPS-induced ALI, primarily mediated by the reduced expression of cytokines and oxidative stress. This suggests that further studies using anti-IL17 in a treatment regime would be highly worthwhile

Effects of cholinergic hipofunction in lung mechanics and histopathology in an experimental model of lung inflammation induced by air pollution in mice

Os motores a diesel são bastante utilizados nos centros urbanos e sua queima é considerada um grande poluidor ambiental e tóxico para a saúde humana. Devido suas características químicas, as partículas de diesel atingem as vias aéreas mais distais, o que pode induzir inflamação pulmonar e piorar doenças como asma brônquica e enfisema pulmonar. Recentemente foi demonstrado por nosso grupo que o sistema colinérgico anti-inflamatório é um importante modulador da inflamação pulmonar. Assim, nosso objetivo no presente estudo foi avaliar se a deficiência colinérgica induzida por alteração genética para redução da expressão da proteína vesicular transportadora de acetilcolina (VAChT) interfere nas alterações funcionais e histopatológicas pulmonares em modelo experimental de instilação repetida de partículas de exaustão de diesel (DEP). Para tanto, camundongos machos geneticamente modificados para redução de VAChT foram utilizados, divididos de acordo com a genotipagem em selvagem (WT) e knock-down para VAChT (KD) e submetidos ao protocolo de exposição de DEP, que consistiu em instilação intranasal de 10uL de DEP na concentração de 3mg/mL por 30 dias (5x por semana). Animais dos grupos controle receberam salina seguindo mesmo protocolo. Foram avaliados: alterações de mecânica do sistema respiratório, resposta inflamatória no lavado broncoalvelar (LBA), imunohistoquimica e Elisa para detecção de citocinas, remodelamento da matriz extracelular pulmonar e presença de muco no epitélio brônquico e nasal. Nossos resultados mostraram que animais selvagens submetidos à DEP apresentaram aumento de macrófagos no LBA e células mononucleares no sangue, da expressão de TNF-alfa, IL-4, IL-6 e IL-13 no tecido pulmonar, de remodelamento de fibras colágenas no tecido e aumento na produção de muco neutro nas vias aéreas quando comparado ao controle exposto à salina. Estas alterações foram associadas a uma piora da função pulmonar. A deficiência colinérgica nos animais que foram submetidos à instilação de DEP induziu um aumento de neutrófilos e linfócitos no LBA e granulócitos no sangue, da expressão de IL-4 e TNF-alfa no pulmão e do conteúdo de fibras elásticas na parede do septo alveolar. Além disso, induziu um aumento de muco ácido no epitélio nasal. Estes dados sugerem que, pelo menos em parte, o sistema colinérgico interfere na inflamação pulmonar induzida por exposição à DEP, uma vez que animais com deficiência colinérgica apresentam piora de alguns parâmetros inflamatórios não observados ou observados em menor escala nos animais selvagensDiesel automotive engines are widely used in urban centers and its exhausts is considered a major environmental and toxic pollutant to human health. Because of their chemical characteristics, diesel particulate reaches more distal airways, which can induce and worsen pulmonary inflammation diseases such as bronchial asthma and pulmonary emphysema. It has recently been demonstrated by our group that the cholinergic anti-inflammatory system is an important modulator of lung inflammation. Thus, the aim of this study was to evaluate whether the cholinergic deficiency induced by reduced expression of the vesicular acetylcholine transporter protein (VAChT) interferes in pulmonary function and histopathological changes in an experimental model of repeated diesel exhaust particles (DEP) instillation. To this end, male mice with reduction in VAChT were used, divided according to genotyping for wild-type (WT) and knock-down for VAChT (KD), and submitted to DEP exposure protocol, which consisted in intranasal instillation of 10 ?L of DEP in a concentration of 3 mg/mL for 30 days (5x per week). Control groups received saline following the same protocol. We evaluated: respiratory mechanics, inflammation in broncoalveolar lavage (BAL), immunohistochemistry and ELISA for cytokine detection, pulmonary extracellular matrix remodeling and bronchial and nasal epithelium mucus. Our results showed that WT animals submitted to DEP protocol showed increased macrophages in BAL and mononuclear cells in peripheral blood, increased expression of TNF-alfa, IL-4, IL-6 and IL-13 in lung tissue, collagen fibers remodeling in lung parenchyma and increase in neutral mucus production in the airways when compared to the saline exposed animals. These changes were associated with worse lung function. The cholinergic deficiency in the animals instilled with DEP induced an increase in BAL neutrophils and lymphocytes and granulocytes in the peripheral blood, in the expression of IL-4 and TNF-alfa and in lung elastic fibers content in alveolar septa. In addition, there was an increase in acid mucus in nasal epithelium. These data suggest that, at least in part, cholinergic system interferes with pulmonary inflammation induced by DEP exposures, since animals with cholinergic deficiency exhibit some inflammatory alterations which are not observed or observed on a smaller scale in wild-type animal

A plant proteinase inhibitor from Enterolobium contortisiliquum attenuates airway hyperresponsiveness, inflammation and remodeling in a mouse model of asthma

Introduction. Proteinase inhibitors have been associated with anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment for asthma. Purpose. The aim of the present study was to evaluate the effects of Enterolobium contortisiliquum trypsin inhibitor (EcTI) on pulmonary mechanical function, eosinophilic recruitment, inflammatory cytokines, remodeling and oxidative stress in an experimental model of chronic allergic pulmonary inflammation. Methods. BALB/c mice were divided into 4 groups: C (saline i.p and inhalations with saline), OVA (ovalbumin i.p and inhalations with ovalbumin); C+EC (saline i.p, inhalations with s aline and treatment with EcTI); OVA+EC (ovalbumin i.p, inhalations with ovalbumin and treatment with EcTI). On day 29, we performed the following tests: resistance (Rrs) and elastance (Ers) of the respiratory system; (b) quantify eosinophils, 8-ISO-PGF2α, collagen and elastic fiber volume fractions; (c) IFN-γ, IL-4, IL-5, IL-13, MMP-9, TIMP-1, TGF-β, iNOS and p65-NFκB-positive cells in the airway and alveolar walls. Results. In OVA+EC group, there was an attenuation of the Rrs and Ers, reduction of eosinophils, IL-4, IL-5, IL-13, IFN-γ, iNOS and p65-NF κB-positive cells compared to OVA group. The 8-ISO-PGF2α, elastic and collagen fibers volume fractions as well as the positive cells for MMP-9, TIMP1 and TGF-β positive cells were decreased in OVA+EC compared to the OVA group. Conclusion. EcTI attenuates bronchial hyperresponsiveness, inflammation, remodeling and oxidative stress activation in this experimental mouse model of asthma